Antigenics, Inc

Protein Design Labs Inc.


34801 Campus Drive
Fremont, CA 94555
Phone: (510) 574-1400
Fax: (510) 574-1500
Email: cc@pdl.com
Web Site: http://www.pdl.com/

 

A. Company Profile

 

Protein Design Labs (NASDAQ:PDL) is a leader in the development of humanized monoclonal antibodies to treat various disease conditions including cancers.

 

B. Products

 

 

Product Pipelines

 

 

Product

 

 

Indication

 

Clinical Status

Anti-alpha5beta1 integrin antibody

 

Solid tumors

 

Phase I

 

1. Anti-alpha5beta1 integrin antibody

 

Anti-alpha5beta1 integrin antibody inhibits angiogenesis, including vessel formation induced by vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), as well as other pro-angiogenic growth factors.